Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy

Br J Haematol. 2013 Apr;161(2):279-80. doi: 10.1111/bjh.12202. Epub 2013 Jan 7.

Authors

Régis Peffault de Latour¹, Aliénor Xhaard, Véronique Fremeaux-Bacchi, Paul Coppo, Anne Marie Fischer, Dominique Helley, Gérard Socié

Affiliation

¹ Service d'Hématologie Greffe, Hôpital Saint-Louis, APHP et Faculté de Médecine, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. regis.peffaultdelatour@sls.aphp.fr.

PMID: 23294015
DOI: 10.1111/bjh.12202

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / administration & dosage*
Hematopoietic Stem Cell Transplantation*
Humans
Male
Middle Aged
Multiple Myeloma / therapy*
Thrombotic Microangiopathies / drug therapy*
Thrombotic Microangiopathies / etiology
Transplantation, Homologous

Substances

Antibodies, Monoclonal, Humanized
eculizumab